Changing Pharmaceutical Industry in focus at BRAC University Seminar
The School of Pharmacy (SoP) of BRAC University hosted a seminar titled "Changing Pharmaceutical Landscape of Bangladesh: Shaping Future Leaders" on the university's Merul Badda campus on 8 May 2025.
The event brought together academics, industry leaders, and officials from regulatory bodies to discuss the evolution of Bangladesh's pharmaceutical industry, recent developments, and the crucial role of future leaders in driving advancements.
Professor Md Selim Reza, Dean of the Faculty of Pharmacy at the University of Dhaka and Member of the Pharmacy Council of Bangladesh (PCB), highlighted the dangers of counterfeit medicines.
Keep updated, follow The Business Standard's Google news channel
Professor Md Abdur Rashid, a former Dean of the faculty and a PCB Member, stressed that environmentally responsible and efficient production methods were vital for the industry's long-term viability.
Another former Dean, Prof Choudhury Mahmood Hasan, also Vice President of the PCB, offered insights on the advantages and limitations of artificial intelligence in pharmaceutical education.
Syed S. Kaiser Kabir, CEO and Managing Director of Renata PLC and Vice President of the Bangladesh Association of Pharmaceutical Industries (BAPI), emphasised the importance of bioequivalence studies for the export of pharmaceutical products from Bangladesh.
Bioequivalence refers to the biochemical similarity between two or more drugs that share the same active ingredients and produce the same desired outcomes for patients.
Md Nasser Shahrear Zahedee, Chairman of Radiant Pharmaceuticals Ltd, urged students to integrate theoretical knowledge with practical applications.
Abdul Muktadir, Managing Director of Incepta Pharmaceuticals Ltd. and President of the BAPI, called for collaborations with international universities and research organisations that focus on synthetic chemistry.
Professor Syed Ferhat Anwar, Vice-Chancellor of BRAC University, spoke about fostering leadership among the next generation of pharmaceutical professionals, highlighting that the university aims to lead from the Global South in research and innovation.
Dr Md Akter Hossain, Director of the Directorate General of Drug Administration, Professor Dr Raushanara Akter, Acting Chairperson of the Sop, Registrar Dr. David Dowland, Professor AFM Yusuf Haider, Acting Dean of the Sop, and Professor Dr Sharmind Neelotpol, Convener of the seminar, also spoke on the occasion.
